Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Toyota Global Sales Fall as China Demand Slumps 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says 
Add as a preferred source on Google
NEW YORK, March 31, 2018 -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive (“Class Period”). The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.
To join the Akorn class action, go to http://www.rosenlegal.com/cases-1301.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Akorn’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’s acquisition of Akorn; (2) Akorn lacked effective internal controls over financial reporting; and (3) as a result, Akorn’s financial statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 7, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1301.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
